SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System
February 03, 2023 15:32 ET | SPR Therapeutics, Inc.
CLEVELAND, Feb. 03, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic...
Lidocaine Ointment Market Report 2022: Featuring Glenmark Pharmaceuticals, Novocol Pharma, AstraZeneca & More
January 16, 2023 09:33 ET | Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Lidocaine Ointment Market, by Formulation, by Age Group, by Application, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity...
Analgesics Global Market Report 2022: Sector to Reach $56.86 Million by 2030 at a CAGR of 4.9%
January 10, 2023 05:18 ET | Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Analgesics Market by Type and by Route of Administration - Global Opportunity Analysis and Industry Forecast 2022-2030" report has been added to ...
Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Company
January 09, 2023 09:03 ET | Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced details for its plan to spin off its current medical device division, known as NewCo, as a...
ZetrOZ presents at the MLB winter meetings to PBATS
ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society
January 05, 2023 10:31 ET | ZetrOZ Systems
SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ZetrOZ Systems hosted a Lunch and Lecture for The Professional Baseball Athletic Trainers Society (PBATS) during the Major League Baseball Winter...
Endonovo Announces Advancement of International “Go to Market” Initiative
December 19, 2022 09:09 ET | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced an aggressive initiative to introduce and develop the sales and benefits of SofPulse®...
Endonovo Announces Plans for Spin-off of Medical IP and Assets
December 15, 2022 09:07 ET | Endonovo Therapeutics, Inc.
New Company To Be Formed for SofPulse® Medical Device Line Los Angeles, CA, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced plans to affect a...
sam®x1 treating lower back injuries to reduce recovery time
Innovative Soft Tissue Healing Treatments Now Available for Chronic Pain Sufferers in Virginia and Mid-Atlantic Region
December 14, 2022 11:31 ET | ZetrOZ Systems
VIRGINIA BEACH, Va., Dec. 14, 2022 (GLOBE NEWSWIRE) -- ZetrOZ Systems announces that the sam®x1, the only wireless ultrasound device with FDA clearance for at-home use, has been launched and is...
Endonovo Launches Telehealth Initiative
December 13, 2022 09:11 ET | Endonovo Therapeutics, Inc.
Expands Patient Education, Access to Non-Opioid Options for Pain Management Los Angeles, CA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the...
Physician Growth Partners advises Wellspring Pain Solutions in transaction with Capitol Pain Institute and Iron Path Capital
December 12, 2022 17:09 ET | Physician Growth Partners
CHICAGO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Physician Growth Partners (“PGP”) is pleased to have represented Bloomington, IN-based Wellspring Pain Solutions (“Wellspring”) in its transaction with...